The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Teladoc Health Inc (NYSE: TDOC) closed at $8.63 in the last session, down -1.26% from day before closing price of $8.74. In other words, the price has decreased by -$1.26 from its previous closing price. On the day, 9.59 million shares were traded. TDOC stock price reached its highest trading level at $9.15 during the session, while it also had its lowest trading level at $8.46.
Ratios:
We take a closer look at TDOC’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.11 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 5.55. For the most recent quarter (mrq), Quick Ratio is recorded 2.52 and its Current Ratio is at 2.61. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.74.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of . The stock’s future direction. In the most recent recommendation for this company, Mizuho on July 25, 2025, initiated with a Neutral rating and assigned the stock a target price of $10.
On November 15, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $14.
Jefferies reiterated its Hold rating for the stock on September 17, 2024, while the target price for the stock was revised from $8 to $10.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 02 ’25 when Catapano Joseph Ronald sold 2,972 shares for $7.88 per share. The transaction valued at 23,434 led to the insider holds 5,361 shares of the business.
DIVITA CHARLES III sold 16,787 shares of TDOC for $127,435 on Sep 11 ’25. The CHIEF EXECUTIVE OFFICER now owns 179,014 shares after completing the transaction at $7.59 per share. On Sep 11 ’25, another insider, DIVITA CHARLES III, who serves as the Officer of the company, bought 16,787 shares for $7.59 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TDOC now has a Market Capitalization of 1531595520 and an Enterprise Value of 1847416448. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.61 while its Price-to-Book (P/B) ratio in mrq is 1.10. Its current Enterprise Value per Revenue stands at 0.731 whereas that against EBITDA is 114.25.
Stock Price History:
The Beta on a monthly basis for TDOC is 1.92, which has changed by -0.027057469 over the last 52 weeks, in comparison to a change of 0.19736934 over the same period for the S&P500. Over the past 52 weeks, TDOC has reached a high of $15.21, while it has fallen to a 52-week low of $6.35. The 50-Day Moving Average of the stock is 4.87%, while the 200-Day Moving Average is calculated to be 3.49%.
Shares Statistics:
According to the various share statistics, TDOC traded on average about 7.28M shares per day over the past 3-months and 10722210 shares per day over the past 10 days. A total of 177.35M shares are outstanding, with a floating share count of 175.47M. Insiders hold about 1.13% of the company’s shares, while institutions hold 73.19% stake in the company. Shares short for TDOC as of 1760486400 were 24930916 with a Short Ratio of 3.42, compared to 1757894400 on 23817885. Therefore, it implies a Short% of Shares Outstanding of 24930916 and a Short% of Float of 15.78.
Earnings Estimates
Its stock is currently analyzed by 2.0 different market analysts. The consensus estimate for the next quarter is -$0.25, with high estimates of -$0.21 and low estimates of -$0.3.
Analysts are recommending an EPS of between -$0.72 and -$1.25 for the fiscal current year, implying an average EPS of -$1.07. EPS for the following year is -$0.88, with 4.0 analysts recommending between -$0.77 and -$0.99.
Revenue Estimates
According to 22 analysts, . The current quarter’s revenue is expected to be $635.04M. It ranges from a high estimate of $648.3M to a low estimate of $627.6M. As of . The current estimate, Teladoc Health Inc’s year-ago sales were $640.49MFor the next quarter, 22 analysts are estimating revenue of $633.03M. There is a high estimate of $650.7M for the next quarter, whereas the lowest estimate is $610.3M.
A total of 24 analysts have provided revenue estimates for TDOC’s current fiscal year. The highest revenue estimate was $2.54B, while the lowest revenue estimate was $2.51B, resulting in an average revenue estimate of $2.52B. In the same quarter a year ago, actual revenue was $2.57BBased on 24 analysts’ estimates, the company’s revenue will be $2.55B in the next fiscal year. The high estimate is $2.62B and the low estimate is $2.51B.
